# [CXCR4]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |2   |
|DLBCL |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|2.08         |
|BL    |Thomas cohort        |2.10         |
|BL    |Panea cohort         |2.00         |
|DLBCL |GAMBL genomes        |2.70         |
|DLBCL |Schmitz cohort       |2.60         |
|DLBCL |Reddy cohort         |1.50         |
|DLBCL |Chapuy cohort        |2.60         |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   |4.603           | 0.000          |
|DLBCL |Yes |No                   |3.731           |18.727          |
|FL    |Yes |No                   |0.000           | 0.000          |

## aSHM regions

|chr_name|hg19_start|hg19_end |region|regulatory_comment|
|--------|----------|---------|------|------------------|
|chr2    |136874728 |136875461|intron|weak_promoter     |

> [!NOTE]
> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2012 by [Khodabakhshi AH](https://pubmed.ncbi.nlm.nih.gov/23131835)